News
IBB
--
0.00%
--
ETFs to Tap Amgen's Drive for Cancer Deal
Zacks.com · 17h ago
The Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 4)
Benzinga · 19h ago
DJ Amgen To Buy Five Prime Therapeutics In A Deal Valued At $1.9 Billion To Boost Cancer Treatment Portfolio -- MarketWatch
Dow Jones · 1d ago
The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 3)
Benzinga · 1d ago
Sector Update: Health Care Stocks Flat to Higher Premarket Thursday
MT Newswires · 1d ago
5 ETF Investing Areas for March to Boost Returns
Zacks.com · 2d ago
DJ Ocugen Stock Soars After Partner Bharat Biotech COVID-19 Vaccine Candidate Shows 81% Efficacy -- MarketWatch
Dow Jones · 2d ago
Ocugen stock soars after partner Bharat Biotech COVID-19 vaccine candidate shows 81% efficacy
Shares of Ocugen Inc. soared 31.0% in premarket trading Wednesday, after the biopharmaceutical company said its co-development partner Bharat Biotech released an interim analysis of its Phase 3 trial of its COVID-19 vaccine candidate, COVAXIN, which demons...
MarketWatch · 2d ago
US Indexes Close Lower Tuesday
GuruFocus News · 2d ago
The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 2)
Benzinga · 2d ago
COVID-19 Convalescent Plasma Study Shows No Benefit, US NIH Stops Trial
The National Institutes of Health (NIH) has halted a trial evaluating the safety and effectiveness<
Benzinga · 2d ago
Sector Update: Health Care Stocks Mostly Flat During Wednesday's Premarket Activity
MT Newswires · 2d ago
The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 1)
Benzinga · 3d ago
Sector Update: Health Care Stocks Mostly Higher Ahead of Tuesday's Market Open
MT Newswires · 3d ago
Athenex stock plunges to pace all decliners after disappointing FDA response to breast cancer treatment NDA
Shares of Athenex Inc. undefined plummeted 54.6% on very active afternoon trading Monday, enough to be the biggest decliner listed on major U.S. exchanges,...
MarketWatch · 4d ago
DJ Athenex Stock Plunges To Pace All Decliners After Disappointing FDA Response To Breast Cancer Treatment NDA -- MarketWatch
Dow Jones · 4d ago
Sector Update: Health Care Stocks Mixed During Monday's Premarket Trading
MT Newswires · 4d ago
Sector Update: Health Care
MT Newswires · 4d ago
Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates
Most Food and Drug Administration decisions scheduled for February were positive, and more importantly five new molecular entities passed FDA muster.
Benzinga · 5d ago
The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and fast, with a skew of small and midcap companies releasing their quarterly results.
Benzinga · 6d ago
Webull provides a variety of real-time IBB stock news. You can receive the latest news about iShares Nasdaq Biotechnology ETF through multiple platforms. This information may help you make smarter investment decisions.